Previous close | 1.0900 |
Open | 1.1000 |
Bid | 1.4000 |
Ask | 4.0000 |
Strike | 22.00 |
Expiry date | 2023-02-17 |
Day's range | 1.0500 - 1.1500 |
Contract range | N/A |
Volume | |
Open interest | 421 |
In this article we are going to estimate the intrinsic value of Corcept Therapeutics Incorporated ( NASDAQ:CORT ) by...
Corcept's (CORT) Cushing's syndrome drug Korlym is witnessing higher sales and a strong uptake since approval. However, sole dependence on Korlym for revenues remains a headwind.
Durect (DRRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.